The treatment paradigm for small-volume, low-grade unifocal or unilateral prostate cancer is shifting from a radical, whole-gland approach toward organ-sparing, focal ablation. The widely ...

Learn more about the stages of prostate cancer from the National Cancer Institute. A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved ...

The new therapy combines two existing cancer drugs, enzalutamide and talazoparib. Enzalutamide, known by its brand name XTANDI, has been used as a treatment for metastatic castration-resistant ...

less onerous and less invasive than currently available treatment options. Prostate cancer that has spread beyond its original site is, unfortunately, incurable in most circumstances. Treatments ...

joins Lady T to discuss the benefits of proton therapy for prostate cancer patients. For more information on MPTC, visit askforprotons.com ...

When Roger Thomsen had his first episode several years ago, the 69-year-old retired repairman felt lightheaded. He checked his pulse. His heart rate was around 200 beats per minute. A typical ...

A new study from Cold Spring Harbor Laboratory Professor Lloyd Trotman and colleagues, published in Science, shows that menadione significantly slows prostate cancer growth in mice and in human ...

another radiotherapy and the last had active surveillance (no active treatment but regular blood tests and scans where required). Fifteen years later and deaths from prostate cancer have been ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies ... gene therapy for ultra-rare ...

David Gray-Pool/Getty King Charles shared a hopeful word about new advances in cancer ... treatment. The news came after the palace announced the King was treated for a benign enlarged prostate ...